Works matching DE "MARAVIROC (Drug)"

Results: 185

Maraviroc - a CCR5 antagonist for the treatment of HIV-1 infection.
Published in:
2015
By:
- Van Der Ryst, Elna
Publication type:
Opinion
In vitro effect of anti-human immunodeficiency virus CCR5 antagonist maraviroc on chemotactic activity of monocytes, macrophages and dendritic cells.
Published in:
Clinical & Experimental Immunology, 2011, v. 166, n. 2, p. 184, doi. 10.1111/j.1365-2249.2011.04409.x
By:
- Rossi, R.;
- Lichtner, M.;
- De Rosa, A.;
- Sauzullo, I.;
- Mengoni, F.;
- Massetti, A. P.;
- Mastroianni, C. M.;
- Vullo, V.
Publication type:
Article
Clinical Management of Treatment-Experienced, HIV/AIDS Patients in the Combination Antiretroviral Therapy Era.
Published in:
PharmacoEconomics, 2010, v. 28, p. 17, doi. 10.2165/11587420-000000000-00000
By:
- Boyd, Mark A.;
- Hill, Andrew M.
Publication type:
Article
CCR5 blockage by maraviroc: a potential therapeutic option for metastatic breast cancer.
Published in:
Cellular Oncology (2211-3428), 2019, v. 42, n. 1, p. 93, doi. 10.1007/s13402-018-0415-3
By:
- Pervaiz, Asim;
- Zepp, Michael;
- Mahmood, Saqib;
- Ali, Doaa Mohamed;
- Berger, Martin R.;
- Adwan, Hassan
Publication type:
Article
In Vitro Immunological Effects of Blocking CCR5 on T Cells.
Published in:
Inflammation, 2015, v. 38, n. 2, p. 902, doi. 10.1007/s10753-014-0052-6
By:
- Yuan, Jing;
- Ren, Han-yun;
- Shi, Yong-jin;
- Liu, Wei
Publication type:
Article
CCR5 Antagonism Impacts Vaccination Response and Immune Profile in HIV-1 Infection.
Published in:
Molecular Medicine, 2012, v. 18, n. 8, p. 1240, doi. 10.2119/molmed.2012.00206
By:
- Westrop, Samantha J.;
- Moyle, Graeme;
- Jackson, Akil;
- Nelson, Mark;
- Mandalia, Sundhiya;
- Imami, Nesrina
Publication type:
Article
In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha.
Published in:
Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-59596-x
By:
- Ashok kumar, Manickam;
- Sonawane, Aanand;
- Sperk, Maike;
- Tripathy, Srikanth P.;
- Neogi, Ujjwal;
- Hanna, Luke Elizabeth
Publication type:
Article
Network meta‐analysis of post‐exposure prophylaxis randomized clinical trials.
Published in:
HIV Medicine, 2021, v. 22, n. 3, p. 218, doi. 10.1111/hiv.12964
By:
- Fernández, I;
- Lazzari, E.;
- Inciarte, A.;
- Diaz‐Brito, V.;
- Milinkovic, A.;
- Arenas‐Pinto, A.;
- Etcheverrry, F.;
- García, F.;
- Leal, L;
- Fernandez, E;
- Gonzalez, E;
- Lucero, C;
- Leon, A;
- Garcıa, F;
- Manzardo, C;
- Nicolas, D;
- Bodro, M;
- del Rıo, A;
- Cardozo, C;
- Cervera, C
Publication type:
Article
Week 96 results of the randomized, multicentre Maraviroc Switch ( MARCH) study.
Published in:
HIV Medicine, 2018, v. 19, n. 1, p. 65, doi. 10.1111/hiv.12532
By:
- Pett, S. L.;
- Amin, J.;
- Horban, A.;
- Andrade‐Villanueva, J.;
- Losso, M.;
- Porteiro, N.;
- Madero, J. S.;
- Belloso, W.;
- Tu, E.;
- Silk, D.;
- Kelleher, A.;
- Harrigan, R.;
- Clark, A.;
- Sugiura, W.;
- Wolff, M.;
- Gill, J.;
- Gatell, J.;
- Clarke, A.;
- Ruxrungtham, K.;
- Prazuck, T.
Publication type:
Article
Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study.
Published in:
HIV Medicine, 2017, v. 18, n. 7, p. 482, doi. 10.1111/hiv.12479
By:
- Poveda, E;
- Hernández‐Quero, J;
- Pérez‐Elías, MJ;
- Ribas, MA;
- Martínez‐Madrid, OJ;
- Flores, J;
- Navarro, J;
- Gutiérrez, F;
- García‐Deltoro, M;
- Imaz, A;
- Ocampo, A;
- Artero, A;
- Blanco, F;
- Bernal, E;
- Pasquau, J;
- Mínguez‐Gallego, C;
- Pérez, N;
- Aiestaran, A;
- García, F;
- Paredes, R
Publication type:
Article
Off-licence use of once-daily maraviroc in children and adolescents with perinatally acquired HIV-1 infection.
Published in:
HIV Medicine, 2017, v. 18, n. 4, p. 311, doi. 10.1111/hiv.12467
By:
- Fraser‐Taliente, T;
- Mackie, NE;
- Kaye, S;
- Nyirenda, M;
- Foster, C
Publication type:
Article
Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch.
Published in:
HIV Medicine, 2015, v. 16, n. 6, p. 388, doi. 10.1111/hiv.12243
By:
- Tiraboschi, JM;
- Muñoz‐Moreno, JA;
- Puertas, MC;
- Alonso‐Villaverde, C;
- Prats, A;
- Ferrer, E;
- Rozas, N;
- Maso, M;
- Ouchi, D;
- Martinez‐Picado, J;
- Podzamczer, D
Publication type:
Article
Efficacy and safety of once-daily maraviroc plus ritonavir-boosted darunavir in pretreated HIV-infected patients in a real-life setting.
Published in:
HIV Medicine, 2014, v. 15, n. 7, p. 417, doi. 10.1111/hiv.12129
By:
- Macías, J;
- Recio, E;
- Márquez, M;
- García, C;
- Jiménez, P;
- Merino, D;
- Muñoz, L;
- Pasquau, J;
- Ojeda, G;
- Bancalero, P;
- Chueca, N;
- Pineda, JA
Publication type:
Article
The XTrack System: Application and Advantage.
Published in:
Intervirology, 2012, v. 55, n. 2, p. 118, doi. 10.1159/000332003
By:
- Klimkait, Thomas
Publication type:
Article
Responses to Switching to Maraviroc-Based Antiretroviral Therapy in Treated Patients with Suppressed Plasma HIV-1-RNA Load.
Published in:
Intervirology, 2012, v. 55, n. 2, p. 172, doi. 10.1159/000332023
By:
- Vitiello, Paola;
- Brudney, Daniel;
- MacCartney, Malcolm;
- Garcia, Ana;
- Smith, Colette;
- Marshall, Neal;
- Johnson, Margaret;
- Geretti, Anna Maria
Publication type:
Article
The utility of maraviroc, an antiretroviral agent used to treat HIV, as treatment for opioid abuse? Data from MRI and behavioural testing in rats.
Published in:
Journal of Psychiatry & Neuroscience, 2021, v. 46, n. 5, p. E548, doi. 10.1503/jpn.200191
By:
- Iriah, Sade C.;
- Borges, Catarina;
- Shalev, Uri;
- Cai, Xuezhu;
- Madularu, Dan;
- Kulkarni, Praveen P.;
- Ferris, Craig F.
Publication type:
Article
Impaired Maraviroc and Raltegravir Clearance in a Human Immunodeficiency Virus-Infected Patient with End-Stage Liver Disease and Renal Impairment: A Management Dilemma.
Published in:
Pharmacotherapy, 2012, v. 32, n. 1, p. e1, doi. 10.1002/PHAR.1003
By:
- Pau, Alice K.;
- Penzak, Scott R.;
- Boyd, Sarita D.;
- McLaughlin, Mary;
- Morse, Caryn G.
Publication type:
Article
Lack of a significant pharmacokinetic interaction between maraviroc and tacrolimus in allogeneic HSCT recipients.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 7, p. 2078, doi. 10.1093/jac/dkv082
By:
- Ganetsky, Alex;
- Miano, Todd A.;
- Hughes, Mitchell E.;
- Vonderheide, Robert H.;
- Porter, David L.;
- Reshef, Ran
Publication type:
Article
Virological failure of patients on maraviroc-based antiretroviral therapy.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 6, p. 1858, doi. 10.1093/jac/dkv026
By:
- Raymond, Stéphanie;
- Maillard, Anne;
- Amiel, Corinne;
- Peytavin, Gilles;
- Trabaud, Mary Anne;
- Desbois, Delphine;
- Bellecave, Pantxika;
- Delaugerre, Constance;
- Soulie, Cathia;
- Marcelin, Anne Geneviève;
- Descamps, Diane;
- Izopet, Jacques
Publication type:
Article
Seminal pharmacokinetics and antiviral efficacy of once-daily maraviroc plus lopinavir/ritonavir in HIV-infected patients.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 9, p. 2586, doi. 10.1093/jac/dku142
By:
- Calcagno, A.;
- Nozza, S.;
- Simiele, M.;
- Milia, M. G.;
- Chiappetta, S.;
- D'Avolio, A.;
- Ghisetti, V.;
- Lazzarin, A.;
- Di Perri, G.;
- Bonora, S.
Publication type:
Article
HIV-2 viral tropism influences CD4+ T cell count regardless of viral load.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 8, p. 2191
By:
- Treviño, Ana;
- Soriano, Vicente;
- Poveda, Eva;
- Parra, Patricia;
- Cabezas, Teresa;
- Caballero, Estrella;
- Roc, Lourdes;
- Rodríguez, Carmen;
- Eiros, Jose M.;
- Lopez, Mariola;
- De Mendoza, Carmen
Publication type:
Article
Virological response to short-course maraviroc monotherapy does not predict viral tropism in HIV-1-infected treatment-naive patients.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 7, p. 1916, doi. 10.1093/jac/dku059
By:
- Hernández-Novoa, Beatriz;
- Madrid-Elena, Nadia;
- Dronda, Fernando;
- Pérez-Elias, María J.;
- Casado, José L.;
- Pérez-Molina, José A.;
- Moreno, Ana;
- Estébanez, Miriam;
- González, Juan;
- Zamora, Javier;
- Moreno, Santiago
Publication type:
Article
Maraviroc, a CCR5 antagonist, ameliorates the development of hepatic steatosis in a mouse model of non-alcoholic fatty liver disease (NAFLD).
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 7, p. 1903, doi. 10.1093/jac/dku071
By:
- Pérez-Martínez, Laura;
- Pérez-Matute, Patricia;
- Aguilera-Lizarraga, Javier;
- Rubio-Mediavilla, Susana;
- Narro, Judit;
- Recio, Emma;
- Ochoa-Callejero, Laura;
- Oteo, José-Antonio;
- Blanco, José-Ramón
Publication type:
Article
Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 study.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 6, p. 1648
By:
- Katlama, Christine;
- Assoumou, Lambert;
- Valantin, Marc-Antoine;
- Soulié, Cathia;
- Duvivier, Claudine;
- Chablais, Laetitia;
- Kolta, Sami;
- Pialoux, Gilles;
- Mercié, Patrick;
- Simon, Anne;
- Costagliola, Dominique;
- Peytavin, Gilles;
- Marcelin, Anne-Genevieve
Publication type:
Article
Viral rebound after switch to maraviroc/raltegravir dual therapy in highly experienced and virologically suppressed patients with HIV-1 infection.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 5, p. 1436, doi. 10.1093/jac/dkt530
By:
- Nozza, Silvia;
- Bigoloni, Alba;
- Calcagno, Andrea;
- Galli, Laura;
- Pignataro, Angela Rosa;
- D'Avolio, Antonio;
- Carbone, Alessia;
- Ripa, Marco;
- Bonora, Stefano;
- Lazzarin, Adriano;
- Castagna, Antonella
Publication type:
Article
Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 3, p. 735
By:
- Meini, Genny;
- Rossetti, Barbara;
- Bianco, Claudia;
- Ceccherini-Silberstein, Francesca;
- Di Giambenedetto, Simona;
- Sighinolfi, Laura;
- Monno, Laura;
- Castagna, Antonella;
- Rozera, Gabriella;
- D'Arminio Monforte, Antonella;
- Zazzi, Maurizio;
- De Luca, Andrea
Publication type:
Article
Highly multidrug-resistant HIV: clonal analysis and therapeutic strategies.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 12, p. 2882, doi. 10.1093/jac/dkt272
By:
- Todesco, Eve;
- Sayon, Sophie;
- Fourati, Slim;
- Tubiana, Roland;
- Simon, Anne;
- Ktorza, Nadine;
- Schneider, Luminita;
- Peytavin, Gilles;
- Malet, Isabelle;
- Van den Eede, Peter;
- Katlama, Christine;
- Calvez, Vincent;
- Marcelin, Anne-Genevieve;
- Wirden, Marc
Publication type:
Article
Primary resistance of CCR5-tropic HIV-1 to maraviroc cannot be predicted by the V3 sequence.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 11, p. 2506, doi. 10.1093/jac/dkt249
By:
- Delobel, Pierre;
- Cazabat, Michelle;
- Saliou, Adrien;
- Loiseau, Claire;
- Coassin, Lucile;
- Raymond, Stéphanie;
- Requena, Mary;
- Marchou, Bruno;
- Massip, Patrice;
- Izopet, Jacques
Publication type:
Article
Pharmacokinetics of maraviroc administered at 150 mg once daily in association with lopinavir/ritonavir in HIV-positive treatment-naive patients.
Published in:
2013
By:
- Calcagno, Andrea;
- Nozza, Silvia;
- de Requena, Daniel Gonzalez;
- Galli, Andrea;
- D'Avolio, Antonio;
- Simiele, Marco;
- Chiappetta, Stefania;
- Di Perri, Giovanni;
- Lazzarin, Adriano;
- Bonora, Stefano
Publication type:
Letter
In vitro effects of the CCR5 inhibitor maraviroc on human T cell function.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 3, p. 577, doi. 10.1093/jac/dks432
By:
- Arberas, H.;
- Guardo, A. C.;
- Bargalló, M. E.;
- Maleno, M. J.;
- Calvo, M.;
- Blanco, J. L.;
- García, F.;
- Gatell, J. M.;
- Plana, M.
Publication type:
Article
Pharmacokinetic interaction between maraviroc and etravirine in HIV-infected patients receiving regimens containing both drugs and no ritonavir-boosted protease inhibitor.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 11, p. 2779
By:
- Lê, Minh Patrick;
- Solas, Caroline;
- Garraffo, Rodolphe;
- Gagnieu, Marie-Claude;
- Muret, Patrice;
- Yeni, Patrick;
- Dhiver, Catherine;
- Katlama, Christine;
- Poizot-Martin, Isabelle;
- Durant, Jacques;
- Peytavin, Gilles
Publication type:
Article
Immune recovery and T cell subset analysis during effective treatment with maraviroc.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 10, p. 2474, doi. 10.1093/jac/dks216
By:
- Cossarini, Francesca;
- Galli, Andrea;
- Galli, Laura;
- Bigoloni, Alba;
- Salpietro, Stefania;
- Vinci, Concetta;
- Della Torre, Liviana;
- Gianotti, Nicola;
- Spagnuolo, Vincenzo;
- Lazzarin, Adriano;
- Castagna, Antonella;
- Nozza, Silvia
Publication type:
Article
Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 6, p. 1479, doi. 10.1093/jac/dks055
By:
- Baroncelli, Silvia;
- Galluzzo, Clementina Maria;
- Weimer, Liliana Elena;
- Pirillo, Maria Franca;
- Volpe, Anna;
- Mercuri, Alessandra;
- Cavalli, Albertina;
- Fragola, Vincenzo;
- Monno, Laura;
- Degli Antoni, Anna;
- Ladisa, Nicoletta;
- Francisci, Daniela;
- Bucciardini, Raffaella;
- Floridia, Marco
Publication type:
Article
Once daily maraviroc 300 mg or 150 mg in combination with ritonavir-boosted darunavir 800/100 mg.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 3, p. 671, doi. 10.1093/jac/dkr493
By:
- Okoli, Chinyere;
- Siccardi, Marco;
- Thomas-William, Sathish;
- Dufty, Ngozi;
- Khonyongwa, Kirstin;
- Ainsworth, Jonathan;
- Watson, John;
- Cook, Roseanne;
- Gandhi, Kate;
- Hickinbottom, Geraldine;
- Owen, Andrew;
- Taylor, Stephen
Publication type:
Article
CNS effects of a CCR5 inhibitor in HIV-infected subjects: a pharmacokinetic and cerebral metabolite study.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 1, p. 206, doi. 10.1093/jac/dkr427
By:
- Garvey, Lucy;
- Nelson, Mark;
- Latch, Ngaire;
- Erlwein, Otto W.;
- Allsop, Joanna M.;
- Mitchell, Ann;
- Kaye, Steve;
- Watson, Victoria;
- Back, David;
- Taylor-Robinson, Simon D.;
- Winston, Alan
Publication type:
Article
Cell disposition of raltegravir and newer antiretrovirals in HIV-infected patients: high inter-individual variability in raltegravir cellular penetration.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 7, p. 1573, doi. 10.1093/jac/dkr151
By:
- Mello, Aurélie Fayet;
- Buclin, Thierry;
- Franc, Claudia;
- Colombo, Sara;
- Cruchon, Sandra;
- Guignard, Nicole;
- Biollaz, Jérôme;
- Telenti, Amalio;
- Decosterd, Laurent A.;
- Cavassini, Matthias
Publication type:
Article
Maraviroc is able to inhibit dual-R5 viruses in a dual/mixed HIV-1-infected patient.
Published in:
2011
By:
- Symons, Jori;
- Van Lelyveld, Steven F. L.;
- Hoepelman, Andy I. M.;
- Van Ham, Petra M.;
- De Jong, Dorien;
- Wensing, Annemarie M. J.;
- Nijhuis, Monique
Publication type:
Case Study
Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 2, p. 265, doi. 10.1093/jac/dkq458
By:
- Vandekerckhove, Linos;
- Verhofstede, Chris;
- Demecheleer, Els;
- De Wit, Stephane;
- Florence, Eric;
- Fransen, Katrien;
- Moutschen, Michel;
- Mostmans, Wendy;
- Kabeya, Kabamba;
- Mackie, Nicola;
- Plum, Jean;
- Vaira, Dolores;
- Baelen, Kurt Van;
- Vandenbroucke, Ina;
- Eygen, Veerle Van;
- Marck, Herwig Van;
- Vogelaers, Dirk;
- Geretti, Anna Maria;
- Stuyver, Lieven J.
Publication type:
Article
Primary resistance to maraviroc in a large set of R5-V3 viral sequences from HIV-1-infected patients.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 12, p. 2502, doi. 10.1093/jac/dkq381
By:
- Seclén, Eduardo;
- González, María del Mar;
- Lapaz, Mariana;
- Rodríguez, Carmen;
- Del Romero, Jorge;
- Aguilera, Antonio;
- De Mendoza, Carmen;
- Soriano, Vincent;
- Poveda, Eva
Publication type:
Article
Overview on Chemokine Co-Receptor-5 (CCR-5) HIV-1 Entry Inhibitors.
Published in:
Journal of Drug Delivery & Therapeutics, 2018, v. 8, n. 4, p. 73, doi. 10.22270/jddt.v8i4.1794
By:
- Kavita, Pant;
- Anita, Singh
Publication type:
Article
Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305).
Published in:
2017
By:
- Gulick, Roy M.;
- Wilkin, Timothy J.;
- Chen, Ying Q.;
- Landovitz, Raphael J.;
- Amico, K. Rivet;
- Young, Alicia M.;
- Richardson, Paul;
- Marzinke, Mark A.;
- Hendrix, Craig W.;
- Eshleman, Susan H.;
- McGowan, Ian;
- Cottle, Leslie M.;
- Andrade, Adriana;
- Marcus, Cheryl;
- Klingman, Karin L.;
- Chege, Wairimu;
- Rinehart, Alex R.;
- Rooney, James F.;
- Andrew, Philip;
- Salata, Robert A.
Publication type:
journal article
Protection Against Rectal Chimeric Simian/Human Immunodeficiency Virus Transmission in Macaques by Rectal-Specific Gel Formulations of Maraviroc and Tenofovir.
Published in:
2015
By:
- Dobard, Charles W.;
- Taylor, Andrew;
- Sharma, Sunita;
- Anderson, Peter L.;
- Bushman, Lane R.;
- Dinh Chuong;
- Chou-Pong Pau;
- Hanson, Debra;
- Lin Wang;
- Garcia-Lerma, J. Gerardo;
- McGowan, Ian;
- Rohan, Lisa;
- Heneine, Walid;
- Chuong, Dinh;
- Pau, Chou-Pong;
- Wang, Lin
Publication type:
journal article
Maraviroc Reduces the Regulatory T-Cell Frequency in Antiretroviral-Naive HIV-Infected Subjects.
Published in:
Journal of Infectious Diseases, 2014, v. 210, n. 6, p. 890, doi. 10.1093/infdis/jiu180
By:
- Pozo-Balado, María Mar;
- Martínez-Bonet, Marta;
- Rosado, Isaac;
- Ruiz-Mateos, Ezequiel;
- Méndez-Lagares, Gema;
- Rodríguez-Méndez, María Mar;
- Vidal, Francisco;
- Muñoz-Fernández, María Angeles;
- Pacheco, Yolanda María;
- Leal, Manuel
Publication type:
Article
Impact of Antiretroviral Therapy Duration and Intensification on Isolated Shedding of HIV-1 RNA in Semen.
Published in:
Journal of Infectious Diseases, 2013, v. 207, n. 8, p. 1226, doi. 10.1093/infdis/jit026
By:
- Osborne, Brendan J. W.;
- Sheth, Prameet M.;
- Yi, Tae Joon;
- Kovacs, Colin;
- Benko, Erika;
- Porte, Charles la;
- Huibner, Sanja;
- Le, Anh Q.;
- Danroth, Ryan;
- Baraki, Bemuluyigza;
- Mazzulli, Tony;
- Brumme, Zabrina L.;
- Kaul, Rupert
Publication type:
Article
A Pilot Trial of Adding Maraviroc to Suppressive Antiretroviral Therapy for Suboptimal CD4+ T-Cell Recovery Despite Sustained Virologic Suppression: ACTG A5256.
Published in:
Journal of Infectious Diseases, 2012, v. 206, n. 4, p. 534, doi. 10.1093/infdis/jis376
By:
- Wilkin, Timothy J.;
- Lalama, Christina M.;
- McKinnon, John;
- Gandhi, Rajesh T.;
- Lin, Nina;
- Landay, Alan;
- Ribaudo, Heather;
- Fox, Lawrence;
- Currier, Judith S.;
- Mellors, John W.;
- Gulick, Roy;
- Tenorio, Allan R.
Publication type:
Article
Single and Multiple Dose Pharmacokinetics of Maraviroc in Saliva, Semen, and Rectal Tissue of Healthy HIV-negative Men.
Published in:
Journal of Infectious Diseases, 2011, v. 203, n. 10, p. 1484, doi. 10.1093/infdis/jir059
By:
- Brown, Kevin C.;
- Patterson, Kristine B.;
- Malone, Stephanie A.;
- Shaheen, Nicholas J.;
- Asher Prince, Heather M.;
- Dumond, Julie B.;
- Spacek, Melissa B.;
- Heidt, Paris E.;
- Cohen, Myron S.;
- Kashuba, Angela D. M.
Publication type:
Article
Deep Sequencing to Infer HIV-1 Co-Receptor Usage: Application to Three Clinical Trials of Maraviroc in Treatment-Experienced Patients.
Published in:
Journal of Infectious Diseases, 2011, v. 203, n. 2, p. 237, doi. 10.1093/infdis/jiq030
By:
- Swenson, Luke C.;
- Mo, Theresa;
- Dong, Winnie W. Y.;
- Xiaoyin Zhong;
- Woods, Conan K.;
- Jensen, Mark A.;
- Thielen, Alexander;
- Chapman, Douglass;
- Lewis, Marilyn;
- James, Ian;
- Heera, Jayvant;
- Valdez, Hernan;
- Harrigan, P. Richard
Publication type:
Article
Genotypic Tests for Determining Coreceptor Usage of HIV-1.
Published in:
2011
By:
- Kuritzkes, Daniel R.
Publication type:
Editorial
Administration of crushed maraviroc via percutaneous gastrostomy tube in a patient with human immunodeficiency virus and progressive multifocal leukoencephalopathy.
Published in:
2019
By:
- Fulco, Patricia Pecora;
- Gatesman, Travis L
Publication type:
Case Study
NEW DRUGS AND DOSAGE FORMS.
Published in:
2016
Publication type:
Product Review